ZBeats Pressroom
Stay up to date with ZBeats announcements, clinical milestones, events, and media coverage.
ZBeats Receives FDA Clearance for ZBPro Diagnostic v2.0, Supporting ECG Analysis Up to 14 Days
STONY BROOK, N.Y., Sept. 15, 2026 /PRNewswire/ — ZBeats Inc. today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance (K261580) for its ZBPro Diagnostic v2.0 software. This clearance expands ZBeats’ independent ECG analysis platform to support recordings from one minute up to 14 days, including Holter configurations and wearable patches.
ZBeats, Inc. Receives FDA 510(k) Clearance for ZBPro Diagnostic, Advancing Access to Scalable Holter ECG Interpretation
STONY BROOK, NY — July 14, 2025 — ZBeats, Inc., a medical technology company advancing clinical-grade ECG interpretation software, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its flagship platform, ZBPro Diagnostic, under submission number K243252.
ZBeats Selects Harbor Labs as Strategic Cybersecurity Partner for ZBPro Platform
Stony Brook, NY – April 1, 2024 – ZBeats Inc., a developer of advanced software for ambulatory cardiac diagnostics, today announced its formal cybersecurity partnership with Harbor Labs, a leading consultancy specializing in cybersecurity assurance for medical devices.
ZBeats and Cymmedico Announce Strategic Manufacturing Partnership to Advance ZBPatch Production
Stony Brook, NY – February 1, 2024 – ZBeats Inc., a medical technology company developing software-driven solutions for ambulatory cardiac diagnostics, today announced a strategic partnership with Cymmedico, a medical manufacturing subsidiary of Cymmetrik Group,
ZBeats Inc. and MySleep LLC Announce Strategic Joint Venture to Expand CardioSleep Monitoring Services
Stony Brook, NY – October 1, 2023 — ZBeats Inc., a digital health company focused on cardiac diagnostics, and MySleep LLC, an independent diagnostic testing facility (IDTF) specializing in sleep medicine, are pleased to announce the formation of a strategic joint venture
ZBeats Launches Feasibility Study of Cloud-Based ECG Diagnostic System for Long-Term Monitoring
Stony Brook, NY – June 8, 2023 – ZBeats Inc., a digital health company focused on transforming cardiac diagnostics, has announced the launch of a feasibility study evaluating a next-generation ECG monitoring system that combines cloud infrastructure and cutting-edge detection software for long-term continuous monitoring (LTCM).